Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Biocon to furnish more data for consideration of Itolizumab in treating COVID patients

Farhat Nasim29 July 2020 4:24 PM IST

Bengaluru: After facing rejection from the Health Ministry, Bengaluru-based drugmaker Biocon is now preparing to present 'more data' for consideration...

COVID Duty: All freshly admitted PG medicos to be roped in post thorough training in Karnataka

Farhat Nasim29 July 2020 10:15 AM IST

Mangaluru: In order to combat growing cases of fatal COVID-19, the freshly admitted Post Graduate (PG) surgeons pursuing their respective specialized...

Fake Odisha Medical council website issuing bogus MBBS, MD, MS registrations; Crime Branch moved

Farhat Nasim28 July 2020 3:27 PM IST

Odisha: Flagging a bogus website, the Odisha Council of Medical Registration (OCMR) has moved a letter with the Crime Branch, seeking action...

DCGI revokes import licenses for rapid diagnostic units of Cadila Healthcare, two others; suspends 15

Farhat Nasim27 July 2020 3:07 PM IST

New Delhi: India's drug regulator has cancelled the rapid diagnostic kit import licences of 3 firms and suspended that of 15 other people saying the...

NPPA revises ceiling price of Budesonide upholding DOP review order; Details

Farhat Nasim26 July 2020 11:15 AM IST

New Delhi: In an implementation of directions given in line with review orders issued by the Department of Pharmaceuticals (DOP), the National...

Sun Pharma arm resolves US antitrust case over generic drug pricing, to pay Rs 1542 crore

Farhat Nasim25 July 2020 11:09 AM IST

Mumbai: Sun Pharmaceutical Industries said on Friday its US-based subsidiary Taro Pharmaceutical Inc has resolved all cases in connection with...

DCGI nod to two cheaper favipiravir versions priced at Rs 59, Rs 39 per tablets

Farhat Nasim24 July 2020 4:55 PM IST

Briton Pharma will be marketing Favipiravir under the brand name Faviton in India and will also export it.

RELIEF: Former Fortis Healthcare promoter Shivinder Singh finally gets bail in Religare money laundering case

Farhat Nasim24 July 2020 4:45 PM IST

New Delhi: In a major relief to former Fortis Healthcare promoter- Shivinder Mohan Singh; the Delhi High Court has finally granted him bail in...

UP: Private Medical Colleges to pay Rs 1 lakh fine for violating Special Fee Packages

Farhat Nasim22 July 2020 5:26 PM IST

Failing to stick to the said charges, the institutes would entice a fine of Rs 1 lakh.

RIP: Founder, Chairman of JB Chemicals Shri JB Mody passes away at 91

Farhat Nasim22 July 2020 3:22 PM IST

New Delhi: A prominent name in the Indian Pharmaceuticals Industry and the Founder and Chairman of JB Chemicals and Pharmaceuticals, Jyotindra...

TN Health Department yet to recover Bond Money from Doctors Flouting Compulsory Service Norms in Two Districts

Madras HC directs ESIC colleges not to force MBBS doctors to serve for five years; refers issue to Division Bench

Farhat Nasim20 July 2020 3:18 PM IST

Chennai: Taking up the issue of mandatory bond service for medicos, the Madras High Court has pronounced that MBBS students of Employees State...

Diabetes Management: Alembic Pharma gets tentative USFDA nod to Empagliflozin, Metformin Hydrochloride tablets

Farhat Nasim20 July 2020 2:13 PM IST

The tentatively approved Empagliflozin and Metformin Hydrochloride tablets are therapeutically equivalent to Synjardy tablets of Boehringer Ingelheim...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok